From Personal Loss to Scientific MissionFor Jinfiniti founder Professor Jin-Xiong She, PhD, the pursuit of healthy longevity began with personal tragedy. Growing up in the rural Chinese countryside, modern medical care was a rare luxury. After losing his sister to a preventable illness and witnessing his father face a near-fatal health crisis, Dr. She vowed to look deeper into human biology to protect others from the same helpless grief.A Career at the Frontiers of MedicineDriven by his childhood mission, Dr. She pursued molecular genetics, earning his PhD from the University of Montpellier in France. Over a spectacular 30-year academic career in the United States, he became an internationally renowned leader in genomic medicine:Elite Leadership: Served as Full and Endowed Professor at the University of Florida and Division Chief of Experimental Pathology.Pioneering Research: Recruited as a Georgia Research Alliance Eminent Scholar, he founded the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia.Global Impact: Authored over 400 peer-reviewed papers, secured $100 million in research funding, and directed massive international clinical screening trials for chronic diseases.The Birth of JinfinitiDespite his academic success, Dr. She grew frustrated by the limitations of traditional healthcare, which merely manages chronic decline. He recognized that the root causes of disease are the exact drivers of cellular aging.Determined to bridge the 30-year gap between lifespan and healthspan, he left academia to found Jinfiniti Precision Medicine. Becoming his own patient, he developed the world’s first consumer intracellular NAD+ test and clinical-grade biomarker panels to help individuals measure, track, and optimize their biological age. Today, Jinfiniti blends cutting-edge genomic data with targeted protocols to shift modern healthcare from reactive treatment to proactive cellular vitality.